Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Endocrine Society presents Scientific Statement on menopausal hormone therapy at ENDO 2010

The Endocrine Society presented its Scientific Statement on menopausal hormone therapy Monday in San Diego, Calif. at ENDO 2010: The 92nd Annual Meeting & Expo.

23 Jun 2010

HealthGrades study examines mortality rates for patients entering hospitals through emergency departments

The quality of emergency medical care at the nation's hospitals varies widely - both individually and by state - according to a new HealthGrades study released today that, for the first time, examines mortality rates for patients entering hospitals through emergency departments.

23 Jun 2010

Excessive, uncontrolled vascular growth leads to development of cavernomas: Researchers

Benign vascular malformations known as cavernomas can occur in many tissues of the body. These abnormalities are characterized by enlarged, instable and unstructured blood vessels. Cavernomas of medical relevance are primarily those of the brain, which develop approximately in one out of two hundred people. In the brain, such growths often remain unnoticed and are typically found by chance in MRI scans. If they grow larger, they often cause unspecific symptoms such as headaches or dizziness.

23 Jun 2010

Three leading scientists gather to discuss Improved Strategies for Pre-clinical Cardiac Testing

Three leading scientists in the field of cardiac safety in pre-clinical drug development are gathering to discuss Improved Strategies for Pre-clinical Cardiac Testing in a free webinar on June 23 at 11:00 a.m. EDT, sponsored by the Drug Safety Council.

22 Jun 2010

Imaging algorithm helps reduce cumulative radiation exposure and number of CT, CTA, perfusion studies

A large, academic medical center implemented an imaging algorithm that allowed radiologists to successfully reduce the cumulative radiation exposure and number of computed tomography (CT) angiography (CTA) and CT perfusion studies performed on patients with aneurysmal subarachnoid hemorrhages (a form of stroke), according to a study published in the July issue of the American Journal of Roentgenology (www.ajronline.org).

22 Jun 2010

Metabolic syndrome can negatively affect donor's kidney function outcome, study finds

People who donate one of their kidneys experience faster deterioration of their other kidney if they have the metabolic syndrome at the time of donation, a new study finds. The results will be presented Sunday at The Endocrine Society's 92nd Annual Meeting in San Diego.

22 Jun 2010

Improving health care for Saskatchewan patients remains a challenge: HQC report

In October 2008 the province's Health Quality Council released its first "state of health care quality" report, called Quality Insight. Key messages in that inaugural report were that limited access to timely data and the absence of an electronic health record were making it hard for HQC, health providers, and system leaders to improve health care for Saskatchewan patients.

22 Jun 2010

Cytochrome P450 plays important role in management of high blood pressure: Researchers

Researchers have found that increasing certain proteins in the blood vessels of mice, relaxed the vessels, lowering the animal's blood pressure. The study provides new avenues for research that may lead to new treatments for hypertension.

22 Jun 2010

ZynxOrder evidence-based order sets implemented into Riverside Health System's EHR system

Zynx Health, the market leader in providing evidence-based and experience-based clinical decision support solutions, today announced the successful implementation of ZynxOrder evidence-based order sets into the Riverside Health System electronic health record (EHR) system.

22 Jun 2010

Dietary antioxidants improve insulin resistance in obese adults, study finds

A diet rich in natural antioxidants improves insulin sensitivity in insulin-resistant obese adults and enhances the effect of the insulin-sensitizing drug metformin, a preliminary study from Italy finds. The results will be presented Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.

22 Jun 2010

NHLBI funds nine research grants to determine safety and efficacy of red blood cell transfusions

The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, is funding nine research grants to determine if the safety and efficacy of red blood cell transfusions vary depending on how long the cells have been stored. One of the grants supports the first large, multi-center, randomized clinical trial to compare outcomes in heart surgery patients who receive transfusions of red blood cells that have been stored for shorter or longer amounts of time.

22 Jun 2010

Four-year clinical study results show sustained effect that Rheos System has on reducing hypertension

CVRx, Inc. announced today the four-year Rheos clinical results from the European study evaluating the Rheos System at the European Society of Hypertension 20th Meeting. The system is the first device designed to treat hypertension (high blood pressure), a leading cause of heart and kidney disease, stroke and death. This device is a future treatment option for the millions of people who cannot control their blood pressure with medications.

22 Jun 2010

Women who experience early menopause may have cardiovascular disease later in life: Study

Women who experience early menopause appear to have more than twice the risk of having a heart attack, stroke or other cardiovascular disease event later in life than do women who do not go through early menopause, a new study indicates. The results will be presented Saturday at The Endocrine Society's 92nd Annual Meeting in San Diego.

22 Jun 2010

Sinapis initiates dosing in Phase I trial of intravenous infusion of methamphetamine

Sinapis Pharma, Inc. announces that its first patients were dosed in a Phase I clinical trial study on June 14, 2010. This study, in human volunteers, is designed to evaluate the safety, pharmacokinetics, and absolute bioavailability of an intravenous infusion of methamphetamine. The first cohort, investigating shorter infusion times, went well. Future cohorts will evaluate longer infusion times and higher drug doses.

21 Jun 2010

Ferring announces availability of LYSTEDA for cyclic heavy menstrual bleeding in U.S.

Ferring Pharmaceuticals Inc. announced today the U.S. commercial availability of LYSTEDA™ (tranexamic acid) tablets, the only non-hormonal and non-surgical therapy indicated specifically for the treatment of women with cyclic heavy menstrual bleeding (HMB). In clinical studies, LYSTEDA significantly reduced menstrual blood loss (MBL) over three and six cycles of use with the reduction seen as early as the first cycle of use.

21 Jun 2010

Independent DMC recommends continuation of BioSante's ongoing LibiGel CV and Breast Cancer Safety Study

BioSante Pharmaceuticals, Inc., today announced that the independent Data Monitoring Committee (DMC) of the ongoing LibiGel® Cardiovascular (CV) and Breast Cancer Safety Study unanimously recommended study continuation without modifications, after its third review of the study's unblinded safety data. The review was based on data from almost 1,500 women-years of exposure.

21 Jun 2010

LIVALO for primary hyperlipidemia or mixed dyslipidemia now available in U.S.

Kowa Pharmaceuticals America, Inc., and Eli Lilly and Company today announced that LIVALO® (pitavastatin) tablets is now available in retail pharmacies throughout the United States. LIVALO, a statin medication approved by the U.S. Food and Drug Administration (FDA) in August 2009 is indicated for adults as an adjunctive therapy to diet for the treatment of primary hyperlipidemia or mixed dyslipidemia. LIVALO is available in doses of 1 mg, 2 mg and 4 mg.

21 Jun 2010

Toshiba's Aquilion ONE dynamic volume CT system improves clinical pathway for patients in ERs

Emergency departments are challenged to streamline patient diagnoses and treatment for a variety of conditions and require a CT system capable of imaging patients quickly, accurately and safely. Toshiba America Medical Systems, Inc.'s Aquilion® ONE 320-detector row CT system is designed for such settings and used to evaluate a range of patients, including cardiac, neuro, stroke and pediatric.

21 Jun 2010

Investment report on NMT Medical released

MicroStockProfit.com announces an investment report featuring NMT Medical Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

21 Jun 2010

Preliminary top-line results from Hematide Phase 3 program for anemia in chronic renal failure patients

Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.

21 Jun 2010

Stroke News and Research

Further Reading

Endocrine Society presents Scientific Statement on menopausal hormone therapy at ENDO 2010

HealthGrades study examines mortality rates for patients entering hospitals through emergency departments

Excessive, uncontrolled vascular growth leads to development of cavernomas: Researchers

Three leading scientists gather to discuss Improved Strategies for Pre-clinical Cardiac Testing

Imaging algorithm helps reduce cumulative radiation exposure and number of CT, CTA, perfusion studies

Metabolic syndrome can negatively affect donor's kidney function outcome, study finds

Improving health care for Saskatchewan patients remains a challenge: HQC report

Cytochrome P450 plays important role in management of high blood pressure: Researchers

ZynxOrder evidence-based order sets implemented into Riverside Health System's EHR system

Dietary antioxidants improve insulin resistance in obese adults, study finds

NHLBI funds nine research grants to determine safety and efficacy of red blood cell transfusions

Four-year clinical study results show sustained effect that Rheos System has on reducing hypertension

Women who experience early menopause may have cardiovascular disease later in life: Study

Sinapis initiates dosing in Phase I trial of intravenous infusion of methamphetamine

Ferring announces availability of LYSTEDA for cyclic heavy menstrual bleeding in U.S.

Independent DMC recommends continuation of BioSante's ongoing LibiGel CV and Breast Cancer Safety Study

LIVALO for primary hyperlipidemia or mixed dyslipidemia now available in U.S.

Toshiba's Aquilion ONE dynamic volume CT system improves clinical pathway for patients in ERs

Investment report on NMT Medical released

Preliminary top-line results from Hematide Phase 3 program for anemia in chronic renal failure patients

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News